What Brooks’ Surge and On’s Slump Say About Brand Strategy
The contrast between Brooks running shoes growth and the On Holding stock decline describes how different athletic footwear market strategy choices are starting to be rewarded, as investors favor dependable specialty execution over lifestyle-fueled expansion when expectations are missed and guidance is cut. One day after Brooks Running reported a record 14 percent revenue growth for the first half of the year, investors sent shares of faster-growing rival On down as much as 22 percent on a weaker-than-expected sales report. On’s second-quarter revenue missed analyst estimates and management trimmed full-year net sales growth guidance to the low-20 percent range, dragging the stock to lows last seen in May. Brooks, a private company, has no share price for the market to punish, but its numbers and channel choices show a calmer, more focused approach to the same running boom.
Brooks: Specialty-First Discipline Over Lifestyle Diversification
Brooks’ 14 percent growth is not explosive, yet it looks well earned because it comes from steady gains in the places committed runners shop. Growth in the first half reached 9 percent in the Americas and 10 percent in Asia-Pacific, while its Europe, Middle East and Africa region surged 39 percent. The brand said it has held the No. 1 spot in United States run-specialty stores for six straight months, a sign that core runners trust its products. The clearest sign of its focus is on the trail: Brooks trail shoes grew 71 percent year on year in the second quarter, with the Cascadia line up 58 percent. "Brooks Running reported 14 percent revenue growth for the first six months of the year, a company record," the company said. This is a strategy built on reliable models like the Adrenaline GTS and Ghost, plus elite race results that reinforce credibility in the specialty channel.
On: Lifestyle Momentum Meets the Reality of Expectations
On is still growing faster than Brooks, but its stock performance shows that speed without consistent delivery is not enough. The company reported second-quarter revenue of 1.05 billion, short of the 1.08 billion analysts expected, with earnings per share roughly in line. Management cut full-year net sales growth guidance to the low-20 percent range from "at least 23 percent," and shares dropped more than 19 percent in midday trading, falling to roughly two-year lows. Regional sales rose 13 percent in the Americas, 20.5 percent in EMEA and 54.7 percent in APAC at constant currency, but sell-through for everyday running products was weaker in a highly promotional U.S. market. At the same time, On deliberately limited wholesale sell-in in the Americas, slowing wholesale growth to 12.7 percent. Founder and Co-CEO David Allemann argued that On was gaining traction with a "movement class" consumer that sees fitness as part of identity, yet Wall Street cared more about missed numbers than aspirational positioning.
Different Market Bets: Specialty Trust Versus Broad Lifestyle Reach
The running shoe brands comparison now looks like a test of two philosophies: Brooks is betting on specialty trust; On is betting on broad lifestyle reach. Brooks has stayed out of much of the lifestyle and direct-to-consumer race that just cost On, leaning instead on run-specialty shops and on elite results that build credibility there. On has pursued younger and lifestyle buyers, expanding quickly across everyday running and casual silhouettes that appeal to people who want performance engineering with cultural relevance. Yet, when wholesale orders slow and the U.S. market turns heavily promotional, that growth machine becomes exposed. On now expects third-quarter growth to trail the fourth quarter while it works through corrective actions in its wholesale business, and its CFO describes an accelerated product rollout over the next 14 months to refresh everyday running franchises. In contrast, Brooks’ numbers suggest that sticking close to core runners can still deliver growth slightly ahead of the global running market.
What the Diverging Paths Signal for the Second Half
The market’s verdict so far is clear: in this phase of the running boom, dependable specialty execution is being rewarded more than flashy lifestyle expansion. On, which grew about 22 percent in the quarter, was punished by investors, while slower-growing Brooks could claim a record first half without facing a public market backlash. ONON stock has fallen over 33 percent this year and nearly 11 percent since its public listing, underlining how quickly sentiment turns when expectations are missed. The second half will test whether Brooks can hold its specialty lead as rivals push into that same channel, and whether On’s corrective wholesale actions and rapid product rollout can rebuild confidence. For now, Brooks running shoes growth looks like the result of knowing exactly who the brand serves and where it wins, while the On Holding stock decline shows the cost of stretching a running idea into a lifestyle promise without consistently hitting the numbers that public investors demand.
